2-(hydroxymethyl)-1,4-dihydropyridin-4-one, 97%, 5g

(R)-2-(1,8-Naphthyridin-2-yl)-4-phenyl-4,5-dihydrooxazole, 98%, 100mg

5-(5,5-dimethyl-1,3-dioxan-2-yl)-4'-trifluoromethylvalerophenone, 97.0%, 1g

1-Bromo-4,5-difluoro-3-ethoxybenzene, 97.0%, 1g

3-(Fluoromethyl)cyclobutanecarboxylic acid, 98%, 250mg

(4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol hydrochloride, 95.0%, 5g

5-O-tert-butyl 1-O-(2,5-dioxopyrrolidin-1-yl) (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanedioate, 99%, 25g

Báscula analítica y de precisión serie Entris® II Modelos con ajuste externo, no certificados, 0,01 g, 1200 g, BCE1202-1S

N-Lauroyl-L-alanine>97.0%(GC)(T)5g

2-(3-(Dimethylamino)propoxy)-5-(trifluoromethyl)aniline, 95.0%, 250mg

SESAMOLIN, 95%, 10mg

5-(4-ethylphenyl)-1,2-oxazole-3-carboxylic acid, 95.0%, 2g

2-((1-Oxo-2,3-dihydro-1H-inden-5-yl)oxy)acetic acid, 98%, 2.5g